2 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow EBV: new trials by email Literature Review of EBV trials Research Report on EBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Golidocitinib Combined With Selinexor for CAEBVD golidocitinib, Selinexor (combination therapy) - Lymphohistiocytosis, EBV | Phase 2 / Phase 3 | Recruiting | Beijing Friendship Hospital | 28 | 2026-01-01 | 2026-01-27 |
| A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® IFN-γ positive selected T-cells - Adenovirus Infection, EBV | Phase 2 | Recruiting | University Hospital, Basel, Switzerland | 30 | 2014-12-01 | 2025-03-20 |
Adenoviridae Infections (1) · Cytomegalovirus Infections (1)
DNA Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Virus Diseases (1)
Combined Modality Therapy (1) · selinexor (1)
Beijing Friendship Hospital (1) · University Hospital, Basel, Switzerland (1)
China (1) · Switzerland (1)
Nina Khanna, Dr. (1)